Revenio Group Oyj (0KFH.L)
EUR 24.35
(2.74%)
EUR 24.35
(2.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 26.34 Million EUR | -10.72% |
| 2022 | 29.68 Million EUR | 34.29% |
| 2021 | 22.1 Million EUR | 29.03% |
| 2020 | 17.13 Million EUR | 36.03% |
| 2019 | 12.59 Million EUR | 23.4% |
| 2018 | 10.2 Million EUR | 25.68% |
| 2017 | 8.12 Million EUR | 15.05% |
| 2016 | 7.05 Million EUR | 22.53% |
| 2015 | 5.76 Million EUR | 30.52% |
| 2014 | 4.41 Million EUR | -21.08% |
| 2013 | 5.59 Million EUR | 13.5% |
| 2012 | 4.92 Million EUR | 44.02% |
| 2011 | 3.42 Million EUR | 640.44% |
| 2010 | -633 Thousand EUR | 0.31% |
| 2009 | -635 Thousand EUR | -116.83% |
| 2008 | 3.77 Million EUR | 0.0% |
| 2005 | 935 Thousand EUR | 200.68% |
| 2004 | -928.66 Thousand EUR | 62.77% |
| 2003 | -2.49 Million EUR | 50.24% |
| 2002 | -5.01 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.1 Million EUR | -46.32% |
| 2024 Q3 | 5.5 Million EUR | 3.77% |
| 2024 Q2 | 5.3 Million EUR | 3.92% |
| 2023 Q2 | 4.7 Million EUR | -24.19% |
| 2023 Q1 | 6.2 Million EUR | -33.92% |
| 2023 FY | 26.5 Million EUR | -10.72% |
| 2023 Q4 | 9.5 Million EUR | 55.74% |
| 2023 Q3 | 6.1 Million EUR | 29.79% |
| 2022 Q1 | 5.6 Million EUR | -22.21% |
| 2022 FY | 29.68 Million EUR | 34.29% |
| 2022 Q4 | 9.38 Million EUR | 21.86% |
| 2022 Q3 | 7.7 Million EUR | 8.45% |
| 2022 Q2 | 7.1 Million EUR | 26.79% |
| 2021 Q1 | 4.5 Million EUR | -47.68% |
| 2021 FY | 22.1 Million EUR | 29.03% |
| 2021 Q4 | 7.19 Million EUR | 22.02% |
| 2021 Q3 | 5.9 Million EUR | 34.09% |
| 2021 Q2 | 4.4 Million EUR | -2.22% |
| 2020 FY | 17.13 Million EUR | 36.03% |
| 2020 Q2 | 3.4 Million EUR | 41.67% |
| 2020 Q3 | 3.6 Million EUR | 5.88% |
| 2020 Q1 | 2.4 Million EUR | -53.78% |
| 2020 Q4 | 8.6 Million EUR | 138.92% |
| 2019 FY | 12.59 Million EUR | 23.4% |
| 2019 Q1 | 2.6 Million EUR | -13.48% |
| 2019 Q4 | 5.19 Million EUR | 33.15% |
| 2019 Q3 | 3.9 Million EUR | 387.5% |
| 2019 Q2 | 800 Thousand EUR | -69.23% |
| 2018 Q1 | 2.1 Million EUR | 22.09% |
| 2018 Q4 | 3 Million EUR | 20.2% |
| 2018 FY | 10.2 Million EUR | 25.68% |
| 2018 Q2 | 2.5 Million EUR | 19.05% |
| 2018 Q3 | 2.5 Million EUR | 0.0% |
| 2017 Q1 | 1.7 Million EUR | -21.22% |
| 2017 FY | 8.12 Million EUR | 15.05% |
| 2017 Q3 | 2.5 Million EUR | 8.7% |
| 2017 Q4 | 1.72 Million EUR | -31.2% |
| 2017 Q2 | 2.3 Million EUR | 35.29% |
| 2016 FY | 7.05 Million EUR | 22.53% |
| 2016 Q4 | 2.15 Million EUR | 13.58% |
| 2016 Q2 | 1.7 Million EUR | 30.77% |
| 2016 Q3 | 1.9 Million EUR | 11.76% |
| 2016 Q1 | 1.3 Million EUR | 3.17% |
| 2015 Q1 | 1.4 Million EUR | 38.2% |
| 2015 FY | 5.76 Million EUR | 30.52% |
| 2015 Q4 | 1.26 Million EUR | -21.25% |
| 2015 Q3 | 1.6 Million EUR | 6.67% |
| 2015 Q2 | 1.5 Million EUR | 7.14% |
| 2014 Q2 | 1.4 Million EUR | 16.67% |
| 2014 Q1 | 1.2 Million EUR | -19.57% |
| 2014 FY | 4.41 Million EUR | -21.08% |
| 2014 Q4 | 1.01 Million EUR | -7.91% |
| 2014 Q3 | 1.1 Million EUR | -21.43% |
| 2013 Q4 | 1.49 Million EUR | -0.53% |
| 2013 Q3 | 1.5 Million EUR | 7.14% |
| 2013 Q1 | 1.2 Million EUR | -69.44% |
| 2013 Q2 | 1.4 Million EUR | 16.67% |
| 2013 FY | 5.59 Million EUR | 13.5% |
| 2012 FY | 4.92 Million EUR | 44.02% |
| 2012 Q1 | 400 Thousand EUR | 1804.76% |
| 2012 Q3 | 1.2 Million EUR | 400.0% |
| 2012 Q2 | -400 Thousand EUR | -200.0% |
| 2012 Q4 | 3.92 Million EUR | 227.25% |
| 2011 Q3 | 1.3 Million EUR | 8.33% |
| 2011 Q4 | 21 Thousand EUR | -98.38% |
| 2011 FY | 3.42 Million EUR | 640.44% |
| 2011 Q1 | 1 Million EUR | 220.05% |
| 2011 Q2 | 1.2 Million EUR | 20.0% |
| 2010 Q3 | 800 Thousand EUR | 366.67% |
| 2010 Q1 | -300 Thousand EUR | -122.22% |
| 2010 FY | -633 Thousand EUR | 0.31% |
| 2010 Q2 | -300 Thousand EUR | 0.0% |
| 2010 Q4 | -833 Thousand EUR | -204.13% |
| 2009 Q1 | -200 Thousand EUR | 0.0% |
| 2009 Q4 | -135 Thousand EUR | -167.5% |
| 2009 FY | -635 Thousand EUR | -116.83% |
| 2009 Q3 | 200 Thousand EUR | 133.33% |
| 2009 Q2 | -600 Thousand EUR | -200.0% |
| 2008 FY | 3.77 Million EUR | 0.0% |
| 2005 FY | 935 Thousand EUR | 200.68% |
| 2004 FY | -928.66 Thousand EUR | 62.77% |
| 2003 FY | -2.49 Million EUR | 50.24% |
| 2002 FY | -5.01 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cegedim SA | 19.98 Million EUR | -31.827% |
| Guerbet SA | 38.67 Million EUR | 31.879% |
| Nexus AG | 24.76 Million EUR | -6.368% |
| Bastide Le Confort Médical SA | 44.22 Million EUR | 40.43% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 84.611% |
| Sartorius Aktiengesellschaft | 541 Million EUR | 95.131% |
| LNA Santé SA | 62.98 Million EUR | 58.173% |
| Siemens Healthineers AG | 2.86 Billion EUR | 99.082% |
| Medios AG | 31.37 Million EUR | 16.028% |
| Equasens Société anonyme | 55.2 Million EUR | 52.284% |
| Stratec SE | 22.88 Million EUR | -15.095% |